Prognostic significance of DR-70 levels in dysplastic colorectal polyps

Gastroenterology Research and Practice

Volumn 2013, Issue , 2013, Pages

  Yesil, Atakan ^a   Babacan Abanonu, Gul ^a   Colak, Yasar ^b   Paker, Nurcan ^c   Gonen, Can ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b Medeniyet University   (Turkey)

^c Duzen Laboratories   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; DR 70; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CANCER SIZE; COLORECTAL POLYP; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DYSPLASTIC COLON POLYP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRECANCER; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

EID: 84890066091     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2013/275392     Document Type: Article

References (28)

1. Day L. W., Walter L. C., Velayos F., Colorectal cancer screening and surveillance in the elderly patient. The American Journal of Gastroenterology 2011 106 7 1197 1206 2-s2.0-79960052322 10.1038/ajg.2011.128
2. Cummings L. C., Cooper G. S., Colorectal cancer screening: update for 2011. Seminars in Oncology 2011 38 4 483 489 2-s2.0-79961002753 10.1053/j.seminoncol.2011.05.002
3. Pawa N., Arulampalam T., Norton J. D., Screening for colorectal cancer: established and emerging modalities. Nature Reviews Gastroenterology and Hepatology 2011 8 12 711 722 2-s2.0-82955195715 10.1038/nrgastro.2011.205
4. Mandel J. S., Screening for Colorectal Cancer. Gastroenterology Clinics of North America 2008 37 1 97 115 2-s2.0-39649083122 10.1016/j.gtc.2007.12.007 (Pubitemid 351289026)
5. Bernal G., Use of RNA isolated from feces as a promising tool for the early detection of colorectal cancer. International Journal of Biological Markers 2012 27 e82 e89
6. Pedrazzani C., Cerullo G., Marrelli D., Fernandes E., Carlucci F., Corso G., Bettarini F., De Stefano A., Roviello F., Is circulating D-dimer level a better prognostic indicator than CEA in resectable colorectal cancer? Our experience on 199 cases. International Journal of Biological Markers 2010 25 3 171 176 2-s2.0-78650809920
7. Kilic M., Yoldas O., Keskek M., Ertan T., Tez M., Gocmen E., Koc M., Prognostic value of plasma D-dimer levels in patients with colorectal cancer. Colorectal Disease 2008 10 3 238 241 2-s2.0-39649106353 10.1111/j.1463-1318. 2007.01374.x (Pubitemid 351284674)
8. Oya M., Akiyama Y., Okuyama T., Ishikawa H., High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. Japanese Journal of Clinical Oncology 2001 31 8 388 394 2-s2.0-0034792951
9. Nagy Z., Horváth O., Kádas J., D-dimer as a potential prognostic marker. Pathology and Oncology Research 2012 18 669 674
10. Small-Howard A. L., Harris H., Advantages of the AMDL-ELISA DR-70 (FDP) assay over carcinoembryonic antigen (CEA) for monitoring colorectal cancer patients. Journal of Immunoassay and Immunochemistry 2010 31 2 131 147 2-s2.0-77951236520 10.1080/15321811003617438
11. Rucker P., Antonio S. M., Braden B., Elevated fibrinogen-fibrin degradation products (FDP) in serum of colorectal cancer patients. Analytical Letters 2004 37 14 2965 2976 2-s2.0-9744250150 10.1081/AL-200035849 (Pubitemid 39587318)
12. Gronostaj K., Richter P., Nowak W., Altered plasma fibrin clot properties in patients with digestive tract cancers: links with the increased thrombin generation. Thrombosis Research 2013 131 3 262 267 10.1016/j.thromres.2012.11. 033
13. Rubio C. A., Kristjansdottir S., Thodleifsson B., The frequency of advanced adenoma in consulting patients: a nationwide survey in Iceland (2003-2006). Colorectal Disease 2012 14 e595 e602
14. Renehan A. G., O'Dwyer S. T., Haboubi N. J., Potten C. S., Early cellular events in colorectal carcinogenesis. Colorectal Disease 2002 4 2 76 89 2-s2.0-0036224194 10.1046/j.1463-1318.2002.00336.x (Pubitemid 34413845)
15. Moreira L., Update on colorectal cancer precursor lesions. Journal of Gastroenterology and Hepatology 2012 35 supplement 1 80 85
16. West A. B., Mitsuhashi T., Cancer or high-grade dysplasia? The present status of the application of the terms in colonic polyps. Journal of Clinical Gastroenterology 2005 39 1 4 6 2-s2.0-11144330664 (Pubitemid 40041334)
17. Gupta N., Bansal A., Rao D., Early D. S., Jonnalagadda S., Wani S. B., Edmundowicz S. A., Sharma P., Rastogi A., Prevalence of advanced histological features in diminutive and small colon polyps. Gastrointestinal Endoscopy 2012 75 5 1022 1030 2-s2.0-84860217417 10.1016/j.gie.2012.01.020
18. Johnson M. E., Feinn R., Anderson J. C., Clinical factors associated with non-polypoid colonic adenomas 6 mm: a prospective study in an asymptomatic population using a high-definition colonoscope. The American Journal of Gastroenterology 2011 106 11 2018 2022 2-s2.0-80655148937 10.1038/ajg.2011.254
19. Cook E. J., Welsh F. K., Chandrakumaran K., Resection of colorectal liver metastases in the elderly: does age matter? Colorectal Disease 2012 14 1210 1216
20. Putzki H., Significance of carcinoembryonic antigen in the treatment of colorectal cancers Zentralblatt fur Chirurgie 1986 111 18 1119 1123 2-s2.0-0023018681
21. Koizumi F., Odagiri H., Fujimoto H., Kawamura T., Ishimori A., Clinical evaluation of four tumor markers (CEA, TPA, CA50 and CA72-4) in colorectal cancer. Rinsho Byori 1992 40 5 523 528 2-s2.0-0026855965
22. Locker G. Y., Hamilton S., Harris J., Jessup J. M., Kemeny N., Macdonald J. S., Somerfield M. R., Hayes D. F., Bast R. C. Jr., ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. Journal of Clinical Oncology 2006 24 33 5313 5327 2-s2.0-33846595479 10.1200/JCO.2006.08.2644 (Pubitemid 46631379)
23. Wu D., Zhou X., Yang G., Xie Y., Hu M., Wu Z., Yang G., Lu M., Clinical performance of the AMDL DR-70(TM) immunoassay kit for cancer detection. Journal of Immunoassay 1998 19 1 63 72 2-s2.0-0031884237
24. Wu D., Zhou X., Yang G., Xie Y., Hu M., Wu Z., Yang G., Lu M., Clinical performance of the AMDL DR-70(TM) immunoassay kit for cancer detection. Journal of Immunoassay 1998 19 1 63 72 2-s2.0-0031884237
25. Kerber A., Trojan J., Herrlinger K., Zgouras D., Caspary W. F., Braden B., The new DR-70 immunoassay detects cancer of the gastrointestinal tract: a validation study. Alimentary Pharmacology and Therapeutics 2004 20 9 983 987 2-s2.0-9944260845 10.1111/j.1365-2036.2004.02212.x (Pubitemid 39593280)
26. Lin S. Z., Chen C. C., Lee K. C., DR-70 immunoassay for the surveillance of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2012 27 547 552
27. Li X., Qiao Z., Long X., Wei J., Cheng Y., Serum concentration of AMDL DR-70 for the diagnosis and prognosis of carcinoma of the tongue. British Journal of Oral and Maxillofacial Surgery 2005 43 6 513 515 2-s2.0-28444463248 10.1016/j.bjoms.2004.11.020 (Pubitemid 41722909)
28. Ding L., Ping S., Jingmei Y., Application of tumor marker of DR-70 in the diagnosis of malignant tumors. Chongqing Medical Journal 1999 28 1 3